Relypsa
Biopharmaceutical company developing drugs for treating cardiovascular and renal diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€9—14m (Dealroom.co estimates Oct 2012.)
Redwood City California (HQ)
Authorizing premium user...